estimated an odds ratio (OR) of breast cancer risk of 2.1 (95% confidence interval (CI) 1.35–3.23, p < 0.001) for ATM pathogenic variant carriers compared to non-carriers. This evidence concerns the gene ATM and breast carcinoma.